CONTINUE TO SITE
OR WAIT null SECS
- About Us
- Advertise
- Editorial
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Incoporating AI into Commercialization Plans
Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.
In this exclusive PC Podcast interview, Steve Silvestro, president of OptimizeRx, a digital communications platform, details:
- The benefits to integrating direct-to-consumer (DTC) and healthcare provider (HCP) marketing strategies with technology, especially for patients and providers
- The application of artificial intelligence (AI) toward the pharma marketing stage of commercialization
- Ways that pharma marketers can navigate the rapidly changing landscape of state-level consumer privacy legislation
- Recommendations for pharma brands as they start to think about 2025 planning
The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.
Related Content:
